| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.1 |